Entrada de Pandipedia

Actualitzat el 12 Jul 20261 fontExplora Pandipedia

Is 80% adherence evidence-based? The review says not as a universal rule

Is 80% medication adherence really a universal cutoff? The review says that number came from an early empirical definition in antihypertensive care, where taking at least 80% was treated as sufficient^[1].

🧵 1/6

But the authors do not treat 80% as a proven standard. They say they could not reject or confirm the validity of the historical 80% threshold, and that it was clearly questioned as a general standard^[2].

🧵 2/6

Why the uncertainty? The review says the needed adherence cutoff can depend on the disease, medication, and patient characteristics, because those factors can change what level still produces a satisfactory outcome^[3].

🧵 3/6

The included studies also spanned different chronic diseases and outcomes, including event-free episodes, hospitalization, cortisone use, reported symptoms, and lipid reduction^[4].

🧵 4/6

A big limitation is measurement heterogeneity. Because adherence was calculated in different ways, the authors could not compare studies quantitatively or standardize adherence rates across them^[5]^[6].

🧵 5/6

Bottom line for evidence reviewers: pre-specify the adherence definition, tie it to the disease and outcome, and be cautious about treating 80% as a default rule^[7]^[8].

🧵 6/6

Clinical Evidence Library

Continua explorant

Comparing semaglutide and tirzepatide for weight loss. Synthesize the comparative evidence in sections covering study designs, populations, total body weight loss outcomes, safety and tolerability, heterogeneity, and head-to-head limitations. Include a compact table distinguishing what is strongly supported from what remains uncertain.Why stopping treatment changes the story on semaglutide versus tirzepatide How do verbal autopsy models estimate the burden of maternal mortality?. Synthesize the InterVA-M validation evidence with the GBD maternal mortality burden findings, separating method, validation, burden estimates, uncertainty, and limitations. Highlight that probabilistic models can approximate cause-specific mortality fractions but also require careful interpretation because case-by-case agreement and data quality constraints affect confidence.The Impact of Language Extinction on Culture Comparative GLP-1 and GIP Weight-Loss Evidence Quiz Exploring the science of telomere lengthening: promising interventions and realistic expectations.. Examines telomerase activators, lifestyle factors, and controversies. Weighs human data against hype and ethical concerns.Long-acting growth hormone in children: what remains uncertain?. Synthesize the consensus and related evidence around which pediatric patients may benefit from long-acting growth hormone and why adherence matters. Separate practical considerations from evidence gaps, especially long-term efficacy, safety, real-world follow-up, and concerns about weekly exposure profiles.How do full-time-equivalent rates change the picture of UK labour-market slack?. Structure the report around the FTEER and FTEUR definitions, then compare them with conventional UK employment and unemployment rates. Include a table of gender, age, qualification, regional, and local economic findings, followed by a limitations section on the 37.5-hour benchmark, desired-hours assumptions, sampling error, and non-causal correlations.